Search research articles
Contact Us
Filters
Showing results (31-40 of 57) with videos related to
Page
of 6
Sort By:
International Journal of Cancer
|
October 19, 2007
Cannabinoids in pancreatic cancer: correlation with survival and pain
Christoph W Michalski, Florian E Oti, Mert Erkan, et al.
Journal of Hypertension
|
October 4, 2012
Circulating anandamide and blood pressure in patients with obstructive sleep apnea
Stefan Engeli, Matthias Blüher, Reiner Jumpertz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 3, 2021
Telomerase therapy attenuates cardiotoxic effects of doxorubicin
Shambhabi Chatterjee, Teresa Hofer, Alessia Costa, et al.
European Heart Journal
|
September 14, 2014
Vascular importance of the miR-212/132 cluster
Regalla Kumarswamy, Ingo Volkmann, Julia Beermann, et al.
Circulation
|
January 30, 2015
Antiandrogenic therapy with finasteride attenuates cardiac hypertrophy and left ventricular dysfunction
Carolin Zwadlo, Elisa Schmidtmann, Malgorzata Szaroszyk, et al.
Gastroenterology
|
July 10, 2003
In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats
Zhaoli Sun, Andrew S Klein, Svetlana Radaeva, et al.
Journal of the American Society of Nephrology : JASN
|
March 20, 2015
Zinc-α2-Glycoprotein Exerts Antifibrotic Effects in Kidney and Heart
Inga Sörensen-Zender, Sagar Bhayana, Nathan Susnik, et al.
European Heart Journal
|
November 27, 2020
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study
Jörg Täubel, Wilfried Hauke, Steffen Rump, et al.
Journal of the American College of Cardiology
|
October 1, 2016
Preclinical Development of a MicroRNA-Based Therapy for Elderly Patients With Myocardial Infarction
Shashi Kumar Gupta, Ariana Foinquinos, Sabrina Thum, et al.
European Journal of Heart Failure
|
January 25, 2024
Efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: Rationale and design of the HF-REVERT trial
Johann Bauersachs, Scott D Solomon, Stefan D Anker, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 57) with videos related to
Sort By:
Page
of 6
International Journal of Cancer
|
October 19, 2007
Cannabinoids in pancreatic cancer: correlation with survival and pain
Christoph W Michalski, Florian E Oti, Mert Erkan, et al.
Journal of Hypertension
|
October 4, 2012
Circulating anandamide and blood pressure in patients with obstructive sleep apnea
Stefan Engeli, Matthias Blüher, Reiner Jumpertz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 3, 2021
Telomerase therapy attenuates cardiotoxic effects of doxorubicin
Shambhabi Chatterjee, Teresa Hofer, Alessia Costa, et al.
European Heart Journal
|
September 14, 2014
Vascular importance of the miR-212/132 cluster
Regalla Kumarswamy, Ingo Volkmann, Julia Beermann, et al.
Circulation
|
January 30, 2015
Antiandrogenic therapy with finasteride attenuates cardiac hypertrophy and left ventricular dysfunction
Carolin Zwadlo, Elisa Schmidtmann, Malgorzata Szaroszyk, et al.
Gastroenterology
|
July 10, 2003
In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats
Zhaoli Sun, Andrew S Klein, Svetlana Radaeva, et al.
Journal of the American Society of Nephrology : JASN
|
March 20, 2015
Zinc-α2-Glycoprotein Exerts Antifibrotic Effects in Kidney and Heart
Inga Sörensen-Zender, Sagar Bhayana, Nathan Susnik, et al.
European Heart Journal
|
November 27, 2020
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study
Jörg Täubel, Wilfried Hauke, Steffen Rump, et al.
Journal of the American College of Cardiology
|
October 1, 2016
Preclinical Development of a MicroRNA-Based Therapy for Elderly Patients With Myocardial Infarction
Shashi Kumar Gupta, Ariana Foinquinos, Sabrina Thum, et al.
European Journal of Heart Failure
|
January 25, 2024
Efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: Rationale and design of the HF-REVERT trial
Johann Bauersachs, Scott D Solomon, Stefan D Anker, et al.
Page
of 6